Author Archives: Marko

Another US State Foots the Hepatitis C Bill – Where can you turn for therapy if you’re not from Delaware?

According to a report on Tuesday, said Delaware State would embark on a new Medicaid policy program all in an attempt to treat hepatitis C patients. Added pressure will not be enough ​ Ever since Obama Administration and lawsuits assumed office, most States are considered to be under pressure from the Delaware's case. For instance, Harvard […]

Getting Hepatitis C Treatment Regardless of Your Fibrosis Score

In the world of Hepatitis C, the chances of getting the medical insurance to cover the high costs of your drugs comes down to a fibrosis score of an individual patient. In the US for example, Medicaid providers will in many cases cover the $94,500 Hepatitis C drug Harvoni costs only to the sickest patients, […]

India grants patent for Sovaldi – Is the Indian Hepatitis C tourism over?

End of Hepatitis C Tourism? For more than a year, Hepatitis C patients who could not afford the high price tag of the novel Hepatitis C drugs in their respective countries, could go to India and buy the medicines they needed to get well for about $2,000. This window that cured thousands and thousands of […]

Hepatitis C had become the deadliest infectious disease in the US

According to the Center for Disease Control and Prevention (CDC), Hepatitis C is currently the most deadly infectious disease in the US. The findings are based on new government data about Hepatitis C related deaths in 2014. What is even more concerning is that in 2014 Hepatitis C accounted for more deaths than 60 other […]

Hepatitis C and SVR – When can you be truly sure you are Hepatitis free?

Meet Steve. Steve is 58 years old and had Hepatitis C for 10 years. With all the rumors about these new direct acting antivirals (DAA) treatment being so successful, he and his doctor make a decision to start sofosbuvir-based treatment of his genotype 1 Hepatitis C condition. During the treatment Steve's well-being in being improved […]

REDEMPTION-1 DAA Trials for Hepatitis C presented at the International Liver Congress 2016

As a part of the effort to solve the unavailability of modern Hepatitis C drugs, REDEMPTION-1 clinical trials were conducted in order to determine the safety and efficacy of generic direct acting antivirals (DAA) to treat Hepatitis C. The trials were lead by Dr. James Freeman of FixHepC Buyers Club who gave a presentation on the outcomes […]

Dr. Freeman’s Presentation at 2016 International Liver Congress – DAA treatment works like a charm!

The International Liver Congress is a 5-day event where scientists and medical experts from all over the globe come up to speed with what is new in the latest liver research. Arguably, it is the biggest event connected with liver diseases in general, and has the biggest impact factor. This year, more than 10,000 scientific […]

$300 Hepatitis C Cure Could be Available Within 2 Years

14th April 2016 – The world renown International Liver Congress 2016 started yesterday. One of the current highlights is a study by DNDi (Drugs for Neglected Diseases initiative) which introduced a new ravidasvir and sofosbuvir combo for treating Hepatitis C. According to clinical studies done on 300 patients in Egypt, the new Hepatitis C combo is […]

Sovaldi was originally priced at $36,000 – Why do Hepatitis C patient have to pay more than $80,000 for it?

By now pretty much everybody knows which common disease will your wallet hate the most: Hepatitis C. Let us look at a list of the most expensive drugs in the US. There are top 10 on the list; can you guess how many of them are Hepatitis C treatments? We will explain an extraordinary story […]

× Chat